Choate Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.7M Buy
50,788
+2,603
+5% +$2.64M 0.91% 18
2025
Q4
$51.8M Buy
48,185
+4,126
+9% +$3.95M 1.02% 15
2025
Q3
$33.6M Buy
44,059
+5,602
+15% +$4.17M 0.7% 24
2025
Q2
$30M Buy
38,457
+7,163
+23% +$5.57M 0.65% 24
2025
Q1
$25.8M Buy
31,294
+12,804
+69% +$10.7M 0.64% 29
2024
Q4
$14.3M Buy
18,490
+40
+0.2% +$33.1K 0.34% 40
2024
Q3
$16.3M Buy
18,450
+194
+1% +$174K 0.42% 34
2024
Q2
$16.5M Sell
18,256
-1,362
-7% -$1.09M 0.43% 32
2024
Q1
$15.3M Buy
19,618
+14
+0.1% +$9.96K 0.41% 29
2023
Q4
$11.4M Buy
19,604
+1,445
+8% +$843K 0.35% 34
2023
Q3
$9.75M Buy
18,159
+1,607
+10% +$828K 0.38% 28
2023
Q2
$7.76M Buy
16,552
+202
+1% +$84.7K 0.32% 31
2023
Q1
$5.61M Sell
16,350
-496
-3% -$167K 0.27% 35
2022
Q4
$6.16M Buy
16,846
+1,907
+13% +$676K 0.37% 35
2022
Q3
$4.83M Sell
14,939
-338
-2% -$107K 0.32% 35
2022
Q2
$4.95M Sell
15,277
-6,290
-29% -$1.89M 0.3% 33
2022
Q1
$6.18M Buy
21,567
+6,788
+46% +$1.75M 0.33% 26
2021
Q4
$4.08M Sell
14,779
-80
-0.5% -$20.3K 0.24% 41
2021
Q3
$3.43M Sell
14,859
-1,760
-11% -$434K 0.22% 45
2021
Q2
$3.81M Sell
16,619
-853
-5% -$171K 0.23% 44
2021
Q1
$3.26M Buy
17,472
+438
+3% +$85.7K 0.2% 48
2020
Q4
$2.88M Buy
17,034
+21
+0.1% +$3.13K 0.17% 52
2020
Q3
$2.52M Sell
17,013
-436
-2% -$67.5K 0.16% 56
2020
Q2
$2.87M Sell
17,449
-1,270
-7% -$195K 0.21% 45
2020
Q1
$2.6M Sell
18,719
-150
-0.8% -$20.6K 0.21% 57
2019
Q4
$2.48M Hold
18,869
0.15% 70
2019
Q3
$2.11M Sell
18,869
-250
-1% -$27.8K 0.13% 74
2019
Q2
$2.12M Sell
19,119
-88
-0.5% -$10.4K 0.13% 76
2019
Q1
$2.49M Sell
19,207
-1,643
-8% -$200K 0.15% 67
2018
Q4
$2.41M Sell
20,850
-2,422
-10% -$271K 0.16% 63
2018
Q3
$2.5M Buy
23,272
+1,400
+6% +$140K 0.14% 61
2018
Q2
$1.87M Sell
21,872
-753
-3% -$61.8K 0.11% 81
2018
Q1
$1.75M Sell
22,625
-344
-1% -$27.7K 0.09% 85
2017
Q4
$1.94M Sell
22,969
-72
-0.3% -$6.13K 0.1% 89
2017
Q3
$1.97M Sell
23,041
-393
-2% -$32.2K 0.11% 86
2017
Q2
$1.93M Sell
23,434
-200
-0.8% -$16.3K 0.11% 82
2017
Q1
$1.99M Sell
23,634
-78
-0.3% -$6.25K 0.12% 82
2016
Q4
$1.74M Sell
23,712
-113
-0.5% -$8.41K 0.11% 80
2016
Q3
$1.91M Buy
23,825
+759
+3% +$60.8K 0.13% 78
2016
Q2
$1.82M Sell
23,066
-4,732
-17% -$356K 0.13% 79
2016
Q1
$2M Buy
27,798
+2,164
+8% +$164K 0.14% 78
2015
Q4
$1.77M Buy
25,634
+158
+0.6% +$13.1K 0.13% 89
2015
Q3
$2.13M Buy
25,476
+339
+1% +$28.6K 0.15% 68
2015
Q2
$2.1M Sell
25,137
-44
-0.2% -$3.35K 0.12% 72
2015
Q1
$1.83M Sell
25,181
-453
-2% -$32.3K 0.1% 84
2014
Q4
$1.77M Buy
25,634
+274
+1% +$18.5K 0.1% 88
2014
Q3
$1.64M Sell
25,360
-924
-4% -$58.5K 0.1% 88
2014
Q2
$1.63M Sell
26,284
-9
-0% -$537 0.1% 94
2014
Q1
$1.55M Sell
26,293
-485
-2% -$27.1K 0.1% 96
2013
Q4
$1.37M Sell
26,778
-682
-2% -$34.2K 0.09% 104
2013
Q3
$1.38M Sell
27,460
-278
-1% -$14.6K 0.1% 99
2013
Q2
$1.36M Buy
+27,738
New +$1.51M 0.11% 98

Other funds holding LLY

Choate Investment Advisors's LLY Position: Q1 2026 in Review

Choate Investment Advisors increased its Eli Lilly (LLY) stake by 5.4% in Q1 2026, buying an estimated $2.64M and bringing the position to 50,788 shares worth $46.7M. The position accounts for 0.91% of the portfolio, ranked #18.

Choate Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $51.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Choate Investment Advisors held 50,788 shares of Eli Lilly worth $46.7M as of Q1 2026.
  • Choate Investment Advisors bought 2,603 Eli Lilly shares in Q1 2026, an estimated $2.64M.
  • Eli Lilly made up 0.91% of Choate Investment Advisors's portfolio in Q1 2026, its #18 holding.
  • Choate Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Choate Investment Advisors's Eli Lilly position peaked at $51.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Choate Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.